Interlaboratory Reliability of Microimmunofluorescence Test for Measurement of Chlamydia pneumoniae -Specific Immunoglobulin A and G Antibody Titers-Reference-Cited by-同舟云学术

Interlaboratory Reliability of Microimmunofluorescence Test for Measurement of Chlamydia pneumoniae -Specific Immunoglobulin A and G Antibody Titers

Published:2004-05 Issue:3 Volume:11 Page:615-617
ISSN:1556-6811
Container-title:Clinical and Vaccine Immunology
language:en
Short-container-title:Clin Vaccine Immunol

Author:

Littman Alyson J.¹²,Jackson Lisa A.¹³,White Emily¹²,Thornquist Mark D.²,Gaydos Charlotte A.⁴,Vaughan Thomas L.¹²

Affiliation:

1. Department of Epidemiology, University of Washington

2. Division of Public Health Sciences, Fred Hutchinson Cancer Research Center

3. Center for Health Studies, Group Health Cooperative, Seattle, Washington

4. Division of Infectious Diseases, Johns Hopkins University, Baltimore, Maryland

Abstract

ABSTRACT To evaluate the reliability of Chlamydia pneumoniae -specific immunoglobulin G (IgG) and IgA antibody titers as measured by the microimmunofluorescence (MIF) test, we compared results from 392 individuals using a standard MIF protocol at two academic laboratories. The kappas for dichotomous titers (≥16 versus <16) were 0.39 for IgA and 0.53 for IgG. Measurement error likely attenuates C. pneumoniae -disease associations; the magnitude of attenuation can be estimated from results of studies such as this one.

Publisher

American Society for Microbiology

Subject

Microbiology (medical),Clinical Biochemistry,Immunology,Immunology and Allergy

Link

https://journals.asm.org/doi/pdf/10.1128/CDLI.11.3.615-617.2004

Reference11 articles.

1. Armstrong B. K. E. White and R. Saracci. 1992. Principles of exposure measurement in epidemiology. Oxford University Press Oxford England.

2. Bennedsen, M., L. Berthelsen, and I. Lind. 2002. Performance of three microimmunofluorescence assays for detection of Chlamydia pneumoniae immunoglobulin M, G, and A antibodies. Clin. Diagn. Lab. Immunol.9:833-839.

3. Danesh, J., P. Whincup, S. Lewington, M. Walker, L. Lennon, A. Thomson, Y. K. Wong, X. Zhou, and M. Ward. 2002. Chlamydia pneumoniae IgA titres and coronary heart disease; prospective study and meta-analysis. Eur. Heart J.23:371-375.

4. Danesh, J., P. Whincup, M. Walker, L. Lennon, A. Thomson, P. Appleby, Y. Wong, M. Bernardes-Silva, and M. Ward. 2000. Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis. BMJ321:208-213.

5. Dowell, S. F., R. W. Peeling, J. Boman, G. M. Carlone, B. S. Fields, J. Guarner, M. R. Hammerschlag, L. A. Jackson, C. C. Kuo, M. Maass, T. O. Messmer, D. F. Talkington, M. L. Tondella, and S. R. Zaki. 2001. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin. Infect. Dis.33:492-503.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined and interaction effect of chlamydia pneumoniae infection and smoking on lung cancer: a case-control study in Southeast China;BMC Cancer;2020-09-22

2. Identification of etiological agents of selected bacterial and viral infections based on serological tests;Postępy Higieny i Medycyny Doświadczalnej;2018-12-31

3. Lung Cancer Among Asian Americans;Cancer Epidemiology Among Asian Americans;2016

4. Neuronal Surface Antibody-Mediated Autoimmune Encephalitis;Seminars in Neurology;2014-11-04

5. Chlamydia Infection and Epidemiology;Intracellular Pathogens I;2014-04-30